(Q44925296)

7 December 2017

Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant (English)

1 reference

7 December 2017

Jong Gwang Kim

1

1 reference

7 December 2017

Sang Kyun Sohn

2

1 reference

7 December 2017

Dong Hwan Kim

3

1 reference

7 December 2017

Nan Young Lee

4

1 reference

7 December 2017

Jang Soo Suh

5

1 reference

7 December 2017

Kun Soo Lee

6

1 reference

7 December 2017

Kyu Bo Lee

7

1 reference

7 December 2017

1 July 2004

1 reference

European Journal of Haematology

7 December 2017

1 reference

7 December 2017

73

1 reference

7 December 2017

1

1 reference

7 December 2017

56-61

1 reference

Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00247.X

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00247.X

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00247.X

Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00247.X

A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell tra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00247.X

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00247.X

10.1111/J.1600-0609.2004.00247.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference